NCT06994767Completed
Speech-derived Digital Biomarkers Study
Speech-derived Digital Biomarkers for Assessing Mild Cognitive Impairment and Alzheimer's Disease Diagnosis Accuracy
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
The goal is to assess the accuracy of an application that analyzes voice characteristics to diagnose patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD). The main question is whether the application's diagnosis is the same as the clinician's for MCI and AD patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 150 (actual)
- First submitted
- 13 May 2025
- Start date
- 19 May 2025
- Primary completion date
- 9 Jan 2026
- Lead sponsor
- Hackensack Meridian Health
- Diseases
- Alzheimer disease
- NCT number
- NCT06994767
What you commit to
- Study type: Interventional
- Participants enrolled: 150
- From 19 May 2025 to the primary completion date, 9 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to provide informed consent
- Individuals with the following medical conditions will be excluded:
- Parkinson's disease ii) Huntington's disease iii) Cancer and active cancer treatments
Other
- All participants below 50 years
- Persons with speech characteristics (heavy accents, slurring, stuttering, etc.) that would interfere with voice recording or voice analysis
Who the study is looking for
- Males and females between the ages of 50 and above
- Willing and capable of participating in all aspects of the study
- Willing and capable of giving informed consent
- Diagnosis of MCI or Alzheimer's by the physician
- For the control group: Without diagnosis of MCI or Alzheimer's or other types of dementia
- Subjects are free of any medical condition(s) that, according to exclusion criteria, might audibly affect voice characteristics
- Subject must be able to speak and read with fluency in the English language.
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hackensack University Medical Center Coordinator of this site? Confirm its status | Hackensack | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.